<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
Allergan Specialty Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 33-0779207
(State of Incorporation or Organization) (I.R.S. Employer
Identification no.)
2525 Dupont Drive, Irvine, CA 92612
(Address of principal executive offices) (zip code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective upon filing pursuant to
General Instruction A.(c), check the following box. |_|
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. |X|
Securities Act registration statement file number to which this form relates
(If applicable): 333-40503
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to Name of Each Exchange on Which
be so Registered Each Class is to be Registered
None
Securities to be registered pursuant to Section 12(g) of the Act:
Class A Common Stock, $0.01 par value
(Title of class)
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
Incorporated by reference to the section entitled "Description of ASTI Capital
Stock" on page 47 of the preliminary prospectus contained in Registrant's
Registration Statement on Form S-1 filed with the Commission on November 18,
1997 (No. 333-40503), as amended.
ITEM 2. EXHIBITS.
Exhibit
Number Description
------ -----------
1. Specimen Class A Common Stock Certificate.(1)
2. Registrant's Certificate of Incorporation.(1)
3. Registrant's Bylaws.(1)
4. Form of Registrant's Restated Certificate of Incorporation.(1)
-------------------
(1) Filed with the Securities and Exchange Commission as an
exhibit to Registrant's Form S-1 Registration Statement, No.
333-40503, as amended, and incorporated herein by reference.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
ALLERGAN SPECIALTY THERAPEUTICS, INC.
(Registrant)
Date: January 21, 1998 By: /s/ SUSAN J. GLASS
--------------------------------
Susan J. Glass, Esq.
General Counsel and Secretary
